Search results
Results From The WOW.Com Content Network
The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II. The drug or other substance has a currently [1] accepted medical use in treatment in the United States. Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.
It also maintains List I of chemicals and List II of chemicals, which contain chemicals that are used to manufacture the controlled substances/illicit drugs. The list is designated within the Controlled Substances Act [ 1 ] but can be modified by the U.S. Attorney General as illegal manufacturing practices change.
Antipsychotics by class Generic name Brand names Chemical class ATC code Typical antipsychotics; Acepromazine: Atravet, Acezine: phenothiazine: N05AA04
Carbonate derivatives of 14β-hydroxycodeine "viz., 14β-hydroxy-6-O-(methoxycarbonyl)codeine, 6-O-methoxycarbonyl-14β-(methoxycarbonyloxy)codeine, and 14β-acetoxy-6-O-methoxy-carbonylcodeine, potential substrates for ring C modification in morphinane (sic) alkaloids, were synthesized for the first time."
Cocaine is the second most popular illegal recreational drug in the United States behind cannabis, [17] and the U.S. is the world's largest consumer of cocaine. [18] In 2020, the state of Oregon became the first U.S. state to decriminalize cocaine. [19] [20] This new law prevents people with small amounts of cocaine from facing jail time.
Those who are eligible typically pay up to $4.50 for a generic drug and $11.20 for a brand-name drug with Extra Help. ... to see if their tier level or your out-of-pocket costs have changed ...
Two Indian chemical companies have been indicted for allegedly importing ingredients for the highly addictive opioid fentanyl into the United States and Mexico, the U.S. Department of Justice said ...
Vermont, a state with a long waiting list for medically based drug treatment, suspended a doctor’s license over incomplete paperwork. As doctors face scrutiny from the DEA, states have imposed even greater regulations severely limiting access to the medications, according to a 2014 report commissioned by the federal agency SAMHSA.